Cormorant Asset Management’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $4.36M | Sell |
|
|||||
|
2021
Q1 | $11.2M | Hold |
|
|||||
|
2020
Q4 | $9.77M | Sell |
|
|||||
|
2020
Q3 | $9.61M | Buy |
|
|||||
|
2020
Q2 | $2.1M | Hold |
|
|||||
|
2020
Q1 | $2.31M | Buy |
|
|||||
|
2019
Q4 | $1.29M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $22.6M | Sell |
|
|||||
|
2018
Q3 | $35.9M | Sell |
|
|||||
|
2018
Q2 | $29.5M | Hold |
|
|||||
|
2018
Q1 | $31.5M | Buy |
|
|||||
|
2017
Q4 | $25.1M | Sell |
|
|||||
|
2017
Q3 | $32.5M | Hold |
|
|||||
|
2017
Q2 | $37.8M | Sell |
|
|||||
|
2017
Q1 | $52.5M | Hold |
|
|||||
|
2016
Q4 | $45.4M | Buy |
|
|||||
|
2016
Q3 | $40.5M | Hold |
|
|||||
|
2016
Q2 | $25.4M | Buy |
|